Medical Condition News

RSS

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Mutations in ARID1a, which are common in many cancer types, disrupt DNA damage repair in cancer cells, allowing the cancer to progress. This gene may also be an Achilles' heel when treating certain tumors, according to a team of researchers at The University of Texas MD Anderson Cancer Center.

12 Jun 2015

Discovery may help scientists attack the root of deadliest brain tumors

Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.

11 Jun 2015

Peanut and nut intake lowers risk of dying from major causes of death

A paper published today in the International Journal of Epidemiology confirms a link between peanut and nut intake and lower mortality rates, but finds no protective effect for peanut butter. Men and women who eat at least 10 grams of nuts or peanuts per day have a lower risk of dying from several major causes of death than people who don't consume nuts or peanuts.

11 Jun 2015

Adding high salt to high-fat diet prevents weight gain in mice

In a study that seems to defy conventional dietary wisdom, University of Iowa scientists have found that adding high salt to a high-fat diet actually prevents weight gain in mice.

11 Jun 2015

Dietary compounds in milk-based products may protect against cardiovascular risk

The Maillard reaction is a chemical reaction between amino acids and reducing sugars that results in browned foods like seared steaks and toasted bread. When proteins and sugars are mixed together and heated, new chemical compounds are formed. Some are responsible for new flavors and some, according to a new study published in the Journal of Dairy Science, may protect us against cardiovascular disease.

11 Jun 2015

Brain Injury Services of SWVA receives WWP grant to provide tele-health program for veterans with TBI

Brain Injury Services of SWVA has received a grant from Wounded Warrior Project (WWP) to provide a unique tele-health program, the Community Living Connection (CLiC) for veterans with traumatic brain injury (TBI), to overcome the diverse challenges of the complex condition. WWP's Grant Program, now in its fourth year, is expanding the availability of programs and services that provide support to this generation of injured service members.

11 Jun 2015

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

11 Jun 2015

NeoGenomics announces launch of new NeoLAB assays to diagnose hematologic diseases

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of its first twelve tests in a new line of "liquid biopsy" or NeoLAB assays using next generation sequencing and other advanced molecular technologies.

11 Jun 2015

PGDx launches LungSelect product to identify genetic alterations in the plasma of NSCLC patients

Personal Genome Diagnostics, Inc., a provider of advanced cancer genome analysis and testing services, today announced the launch of its LungSelect product that identifies the most common, clinically actionable genetic alterations in the plasma of non-small cell lung cancer (NSCLC) patients.

11 Jun 2015

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Contrary to current medical dogma, researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that the common antibiotic azithromycin kills many multidrug-resistant bacteria very effectively — when tested under conditions that closely resemble the human body and its natural antimicrobial factors.

11 Jun 2015

Only one in five patients qualified for free 'midlife MOT' takes NHS heart health check-ups

Only one in five patients eligible for a free "midlife MOT" on the NHS took up the offer in the first four years of the programme.

11 Jun 2015

SQUIRE phase III study shows necitumumab improves median overall survival in squamous NSCLC patients

This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.

11 Jun 2015

Protein-signaling process accelerates work of gene mutation linked to common form of adult leukemia

In preliminary experiments with mice and lab-grown cells, Johns Hopkins Kimmel Cancer Center scientists have found that a protein-signaling process accelerates the work of the gene most frequently mutated in a common form of adult leukemia and is likely necessary to bring about the full-blown disease.

11 Jun 2015

Physical activities may not protect against underlying markers for Alzheimer's disease

While participating in physical activities such as bike riding, dancing, walking and gardening and mentally stimulating activities such as crosswords and reading may reduce the risk of Alzheimer's disease, they may not do so by affecting the underlying markers for the disease, according to a study published in the June 10, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

11 Jun 2015

Specialized brain proteins may be detected in the blood samples of individuals with Alzheimer's disease

Specialized brain proteins that are involved in the removal of damaged nerve cell materials may be detected in the blood of people who were diagnosed with mild cognitive impairment or dementia due to Alzheimer's disease.

11 Jun 2015

Scientists find new way of classifying brain cancers

Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.

11 Jun 2015

Sleep disorder risk among college freshmen may predict retention, academic success

A new study suggests that the risk for sleep disorders among college freshmen may be a predictor of retention and academic success.

11 Jun 2015

New web-based community portal aims to improve diagnosis and treatment for sleep apnea

A new web-based community portal, http://www.MyApnea.Org, is recruiting patients, caregivers and those at risk for sleep apnea to join a growing community of patients and researchers to better understand sleep apnea through information sharing, support and research.

11 Jun 2015

Scientists and clinicians from across the UK come together to address treatment of brain tumors

In an exciting step forward to finding a cure for brain tumours, which kill more children and adults under the age of 40 than any other cancer, the national charity Brain Tumour Research brought together a group of leading brain tumour scientists and clinicians to help accelerate vital research into this devastating disease.

11 Jun 2015

Paediatric outpatient study compares effectiveness of three alternative treatments for type 1 diabetes

A Montréal research team, co-supervised by Dr. Rémi Rabasa-Lhoret from the IRCM and Dr. Laurent Legault from the Montreal Children's Hospital, undertook the first paediatric outpatient study to compare three alternative treatments for type 1 diabetes.

11 Jun 2015

Medical Condition News

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Discovery may help scientists attack the root of deadliest brain tumors

Peanut and nut intake lowers risk of dying from major causes of death

Adding high salt to high-fat diet prevents weight gain in mice

Dietary compounds in milk-based products may protect against cardiovascular risk

Brain Injury Services of SWVA receives WWP grant to provide tele-health program for veterans with TBI

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

NeoGenomics announces launch of new NeoLAB assays to diagnose hematologic diseases

PGDx launches LungSelect product to identify genetic alterations in the plasma of NSCLC patients

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Only one in five patients qualified for free 'midlife MOT' takes NHS heart health check-ups

SQUIRE phase III study shows necitumumab improves median overall survival in squamous NSCLC patients

Protein-signaling process accelerates work of gene mutation linked to common form of adult leukemia

Physical activities may not protect against underlying markers for Alzheimer's disease

Specialized brain proteins may be detected in the blood samples of individuals with Alzheimer's disease

Scientists find new way of classifying brain cancers

Sleep disorder risk among college freshmen may predict retention, academic success

New web-based community portal aims to improve diagnosis and treatment for sleep apnea

Scientists and clinicians from across the UK come together to address treatment of brain tumors

Paediatric outpatient study compares effectiveness of three alternative treatments for type 1 diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News